Charles Schwab’s Dare Bioscience DARE Stock Holding History

Charles Schwab’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,544	Closed	-$10.3K	–	3522
2024 Q2	$10.3K	Hold	2,544	–	–	﹤0.01%	3613
2024 Q1	$15K	Hold	2,544	–	–	﹤0.01%	3446
2023 Q4	$9.43K	Hold	2,544	–	–	﹤0.01%	3527
2023 Q3	$14.1K	Hold	2,544	–	–	﹤0.01%	3539
2023 Q2	$27.8K	Hold	2,544	–	–	﹤0.01%	3518
2023 Q1	$31.8K	Hold	2,544	–	–	﹤0.01%	3439
2022 Q4	$25.3K	Hold	2,544	–	–	﹤0.01%	3473
2022 Q3	$31K	Hold	2,544	–	–	﹤0.01%	3423
2022 Q2	$38K	Hold	2,544	–	–	﹤0.01%	3429
2022 Q1	$46K	Hold	2,544	–	–	﹤0.01%	3539
2021 Q4	$62K	Hold	2,544	–	–	﹤0.01%	3490
2021 Q3	$51K	Buy	+2,544	New	+$50.2K	﹤0.01%	3447
2021 Q2	–	Sell	-1,677	Closed	-$35K	–	3442
2021 Q1	$35K	Buy	+1,677	New	+$40.9K	﹤0.01%	3474

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab's DARE Position: Q3 2024 in Review

Charles Schwab sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 2,544 shares — an estimated $10.3K sold.

Charles Schwab first reported a position in DARE in Q1 2021 and held it in 13 quarters. The position peaked at $62K in Q4 2021. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Charles Schwab reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
Charles Schwab sold 2,544 Dare Bioscience shares in Q3 2024, an estimated $10.3K.
Charles Schwab first reported a position in Dare Bioscience in Q1 2021 and held it in 13 quarters.
Charles Schwab's Dare Bioscience position peaked at $62K in Q4 2021.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.